Contact this trialFirst, we need to learn more about you.
Wnt Pathway Inhibitor
Lorecivivint for Osteoarthritis
Recruiting1 awardPhase 3
This trial will study the long-term effects of a drug called lorecivivint on people with knee osteoarthritis. The first part of the study will be placebo-controlled (meaning some people will take a fake pill), but after that it will be open-label (meaning everyone will take the real drug).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.